Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2017
The 7th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland
Presentation Date(s):- May 5 – 8, 2017
- Total Presentations: 359
-
+
Immunotherapies and targeted therapies in advanced NSCLC
- Type: Proffered Paper session
- Presentations: 6
- Moderators:L. Paz-Ares
- Coordinates: 5/06/2017, 14:45 - 16:15, Room B
-
+
83O - A phase II study of durvalumab (MEDI4736) for previously treated patients with stage IV squamous NSCLC (SqNSCLC): Lung-MAP Sub-study SWOG S1400A
14:45 - 15:00 | Author(s): V. Papadimitrakopoulou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Poster Display Session
- Type: Poster Display Session
- Presentations: 142
- Coordinates: 5/07/2017, 12:30 - 13:00, Hall 1
-
+
143TiP - IMpower110: Phase III trial of 1L atezolizumab in PD-L1–selected chemotherapy-naive NSCLC
12:30 - 12:30 | Author(s): J. Jassem
- Abstract
Loading...
-
+
Targeted therapies and immunotherapies
- Type: Poster Discussion session
- Presentations: 10
- Moderators:S. Ekman
- Coordinates: 5/07/2017, 14:45 - 15:45, Room W
-
+
90PD - Previously treated advanced NSCLC cohort from a multi-disease phase 1 study of ramucirumab (R) plus pembrolizumab (P): Efficacy and safety data
14:45 - 14:45 | Author(s): R.S. Herbst
- Abstract
Loading...
